Large hospital networks abuse the federal 340B drug discount program that was intended to boost small care providers. | ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

The University of Miami Health Systems allegedly deleted a recent social media post celebrating an international expansion, ...

Discount drug program requires drug companies to sell deeply discounted drugs to hospitals that serve high numbers of low-income patients.

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

The Centers for Medicare & Medicaid Services Oct. 31 released its calendar year 2026 final rule for the physician fee schedule.

PHILADELPHIA, November 03, 2025--(BUSINESS WIRE)--IntegriChain, the leading provider of pharma revenue optimization ...

CMS finalizes 2026 physician fee schedule, introducing two conversion factors and updates to practice expense methodology for Medicare payments.

Theravance Biopharma, Inc. today announced that it will be participating at the 36th International Symposium on the Autonomic Nervous System, organized by the American Autonomic Society (AAS), taking ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Readiness in Action During the forum, The Craneware Group demonstrated 340B rebate functionality within Trisus ®, its ...